Yousif Capital Management, LLC Repligen Corp Transaction History

Yousif Capital Management, LLC

$8.96 Billion
Q3 2024

A detailed history of Yousif Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Yousif Capital Management, LLC holds 17,104 shares of RGEN stock, worth $2.46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

17,104

Previous 19,691 13.14%

Holding current value

$2.46 Million

Previous $2.48 Million 2.54%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$119.79 - $167.35 $309,896 - $432,934	-2,587 Reduced 13.14%	17,104 $2.55 Million
Q2 2024 Jul 31, 2024	SELL	$120.0 - $182.95 $219,000 - $333,883	-1,825 Reduced 8.48%	19,691 $2.48 Million
Q1 2024 Apr 26, 2024	SELL	$170.78 - $208.42 $94,612 - $115,464	-554 Reduced 2.51%	21,516 $3.96 Million
Q4 2023 Feb 01, 2024	SELL	$114.17 - $185.35 $11,873 - $19,276	-104 Reduced 0.47%	22,070 $3.97 Million
Q3 2023 Oct 30, 2023	SELL	$138.78 - $176.51 $172,087 - $218,872	-1,240 Reduced 5.3%	22,174 $3.53 Million
Q2 2023 Aug 02, 2023	SELL	$138.42 - $180.31 $114,888 - $149,657	-830 Reduced 3.42%	23,414 $3.31 Million
Q1 2023 May 02, 2023	SELL	$154.26 - $198.1 $26,224 - $33,677	-170 Reduced 0.7%	24,244 $4.08 Million
Q4 2022 Jan 09, 2023	SELL	$162.42 - $220.56 $46,289 - $62,859	-285 Reduced 1.15%	24,414 $0
Q3 2022 Nov 04, 2022	SELL	$160.42 - $256.21 $399,445 - $637,962	-2,490 Reduced 9.16%	24,699 $4.62 Million
Q2 2022 Aug 01, 2022	BUY	$140.68 - $188.02 $237,608 - $317,565	1,689 Added 6.62%	27,189 $4.42 Million
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $135,238 - $216,428	-839 Reduced 3.19%	25,500 $4.8 Million
Q4 2021 Jan 31, 2022	BUY	$247.59 - $304.47 $6.52 Million - $8.02 Million	26,339 New	26,339 $6.98 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.

Account

Yousif Capital Management, LLC Repligen Corp Transaction History